NYLI MacKay Strategic Bond Class A (MASAX)
Nasdaq • Currently unchanged in today's trading session
1 member of Congress has disclosed 1 trade in NYLI MacKay Strategic Bond Class A (MASAX) via STOCK Act filings. The most recent disclosure was a purchase by Stephanie I. Bice on 8 April 2022. Aggregate disclosed activity totals roughly $32.5K in purchases (midpoint estimates from bracketed disclosure amounts).
NYLI MacKay Strategic Bond Class A is currently trading at $8.69, positioned at 21% of its 52-week range ($8.63 – $8.91).
Want to automatically copy Pelosi trades?
Mirror Nancy Pelosi's portfolio with just one click on eToro.
Copy Trading does not amount to investment advice. The value of your investments may go up or down. Your capital is at risk.
Past Performance is not an indication of future results.
NYLI MacKay Strategic Bond Class A Price History and Technical Analysis
Congressional Trading Activity for MASAX
| No data | |||||||
Select transactions to view their annotations on the chart
Similar Stocks
Based on congressional trading patterns
Frequently Asked Questions about MASAX
- Which members of Congress have traded MASAX?
- 1 member of Congress has disclosed 1 trade in NYLI MacKay Strategic Bond Class A (MASAX) under the STOCK Act: Stephanie I. Bice.
- When was MASAX most recently disclosed by Congress?
- The most recent MASAX disclosure was a purchase by Stephanie I. Bice on 8 April 2022.
- What is the total disclosed congressional trading volume for MASAX?
- Members of Congress have disclosed approximately $32.5K in MASAX purchases (midpoint estimate derived from the bracketed amount ranges used in STOCK Act filings).
- How can I track new congressional trades in MASAX?
- This MASAX page updates as soon as new STOCK Act disclosures are filed for NYLI MacKay Strategic Bond Class A. Every trade, politician, transaction date and amount range is surfaced above, typically within hours of the official filing appearing on the House or Senate disclosure portals.
Track MASAX in Congress
See when politicians buy or sell this stock